Delivery Order SPE2DB22D3010-SPE2DB25FP3BS
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $8.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $5,863.25 and a completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a ceiling value of $1,260.82 and an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $2,667.94. This delivery order represents a non-competitive, firm fixed-price procurement conducted without set-aside provisions. The order is due for completion by July 25, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,977.70 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The order, valued at $2,388.72, is a firm fixed-price contract with an ultimate completion date of August 2, 2024. Amerisourcebergen is providing these prescription medications without any set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999, held...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.24 to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a diabetes medication. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a contract ceiling value of $2,670.49 and an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has a total potential value of $12,852.36 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will perform the work from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is part of a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,756.55 and a performance period through June 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,143,237 units of the diabetes medication Glimepiride 4 mg tablets. The delivery order, valued at $5,993.70, is a firm fixed-price contract with a completion date of May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The contract is part of a larger...